Literature DB >> 21156285

Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas.

Massimo Squatrito1, Cameron W Brennan, Karim Helmy, Jason T Huse, John H Petrini, Eric C Holland.   

Abstract

Maintenance of genomic integrity is essential for adult tissue homeostasis and defects in the DNA-damage response (DDR) machinery are linked to numerous pathologies including cancer. Here, we present evidence that the DDR exerts tumor suppressor activity in gliomas. We show that genes encoding components of the DDR pathway are frequently altered in human gliomas and that loss of elements of the ATM/Chk2/p53 cascade accelerates tumor formation in a glioma mouse model. We demonstrate that Chk2 is required for glioma response to ionizing radiation in vivo and is necessary for DNA-damage checkpoints in the neuronal stem cell compartment. Finally, we observed that the DDR is constitutively activated in a subset of human GBMs, and such activation correlates with regions of hypoxia.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21156285      PMCID: PMC3818087          DOI: 10.1016/j.ccr.2010.10.034

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  58 in total

Review 1.  DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme?

Authors:  D Durocher; S P Jackson
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

2.  Mutation analysis of the hCHK2 gene in primary human malignant gliomas.

Authors:  Y Ino; D C Wahrer; D W Bell; D A Haber; D N Louis
Journal:  Neurogenetics       Date:  2000-09       Impact factor: 2.660

3.  Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response.

Authors:  Melissa T Jack; Richard A Woo; Atsushi Hirao; Alison Cheung; Tak W Mak; Patrick W K Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-03       Impact factor: 11.205

4.  DNA damage-induced activation of p53 by the checkpoint kinase Chk2.

Authors:  A Hirao; Y Y Kong; S Matsuoka; A Wakeham; J Ruland; H Yoshida; D Liu; S J Elledge; T W Mak
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

5.  Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells.

Authors:  Y Hirose; M S Berger; R O Pieper
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

6.  Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells.

Authors:  Nikki Charles; Tatsuya Ozawa; Massimo Squatrito; Anne-Marie Bleau; Cameron W Brennan; Dolores Hambardzumyan; Eric C Holland
Journal:  Cell Stem Cell       Date:  2010-02-05       Impact factor: 24.633

7.  Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas.

Authors:  J Bartkova; P Hamerlik; M-T Stockhausen; J Ehrmann; A Hlobilkova; H Laursen; O Kalita; Z Kolar; H S Poulsen; H Broholm; J Lukas; J Bartek
Journal:  Oncogene       Date:  2010-06-28       Impact factor: 9.867

8.  PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.

Authors:  C Dai; J C Celestino; Y Okada; D N Louis; G N Fuller; E C Holland
Journal:  Genes Dev       Date:  2001-08-01       Impact factor: 11.361

9.  Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress.

Authors:  I M Ward; J Chen
Journal:  J Biol Chem       Date:  2001-10-22       Impact factor: 5.157

10.  Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.

Authors:  Atsushi Hirao; Alison Cheung; Gordon Duncan; Pierre-Marie Girard; Andrew J Elia; Andrew Wakeham; Hitoshi Okada; Talin Sarkissian; Jorge A Wong; Takashi Sakai; Elisa De Stanchina; Robert G Bristow; Toshio Suda; Scott W Lowe; Penny A Jeggo; Stephen J Elledge; Tak W Mak
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

View more
  108 in total

Review 1.  Regulation of mammalian target of rapamycin complex 1 (mTORC1) by hypoxia: causes and consequences.

Authors:  Hakan Cam; Peter J Houghton
Journal:  Target Oncol       Date:  2011-04-16       Impact factor: 4.493

2.  The Mre11 complex suppresses oncogene-driven breast tumorigenesis and metastasis.

Authors:  Gaorav P Gupta; Katelynd Vanness; Afsar Barlas; Katia O Manova-Todorova; Yong H Wen; John H J Petrini
Journal:  Mol Cell       Date:  2013-10-10       Impact factor: 17.970

3.  Radiation promotes invasiveness of non-small-cell lung cancer cells through granulocyte-colony-stimulating factor.

Authors:  Y-H Cui; Y Suh; H-J Lee; K-C Yoo; N Uddin; Y-J Jeong; J-S Lee; S-G Hwang; S-Y Nam; M-J Kim; S-J Lee
Journal:  Oncogene       Date:  2015-02-02       Impact factor: 9.867

4.  A functional screen identifies miRs that induce radioresistance in glioblastomas.

Authors:  Patryk Moskwa; Pascal O Zinn; Young Eun Choi; Sachet A Shukla; Wojciech Fendler; Clark C Chen; Jun Lu; Todd R Golub; Anita Hjelmeland; Dipanjan Chowdhury
Journal:  Mol Cancer Res       Date:  2014-09-25       Impact factor: 5.852

5.  Joint Bayesian variable and graph selection for regression models with network-structured predictors.

Authors:  Christine B Peterson; Francesco C Stingo; Marina Vannucci
Journal:  Stat Med       Date:  2015-10-29       Impact factor: 2.373

6.  Whole-transcriptomic Profile of SK-MEL-3 Melanoma Cells Treated with the Histone Deacetylase Inhibitor: Trichostatin A.

Authors:  Elizabeth A Mazzio; Karam F A Soliman
Journal:  Cancer Genomics Proteomics       Date:  2018 Sep-Oct       Impact factor: 4.069

Review 7.  Cancer stem cells and radioresistance.

Authors:  Kiera Rycaj; Dean G Tang
Journal:  Int J Radiat Biol       Date:  2014-03-07       Impact factor: 2.694

8.  The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas.

Authors:  Daniela F Quail; Robert L Bowman; Leila Akkari; Marsha L Quick; Alberto J Schuhmacher; Jason T Huse; Eric C Holland; James C Sutton; Johanna A Joyce
Journal:  Science       Date:  2016-05-20       Impact factor: 47.728

9.  Checkpoint Kinase 2 Negatively Regulates Androgen Sensitivity and Prostate Cancer Cell Growth.

Authors:  Huy Q Ta; Melissa L Ivey; Henry F Frierson; Mark R Conaway; Jaroslaw Dziegielewski; James M Larner; Daniel Gioeli
Journal:  Cancer Res       Date:  2015-11-16       Impact factor: 12.701

10.  Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.

Authors:  Wei Yang; Liangli Wang; Gabriele Roehn; Robert D Pearlstein; Francis Ali-Osman; Hongjie Pan; Roland Goldbrunner; Matthew Krantz; Christoph Harms; Wulf Paschen
Journal:  Cancer Sci       Date:  2012-11-28       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.